Intensity Modulated Radiation Therapy Market - Radiation Type (Proton, Electron, Photon, Carbon-ion), Application (Prostate, Lung, Breast, Brain, & Gynecological Cancer), End use (Hospital, Standalone Radiation Therapy Center)– Global Forecast, 2023-2032

Intensity Modulated Radiation Therapy Market - Radiation Type (Proton, Electron, Photon, Carbon-ion), Application (Prostate, Lung, Breast, Brain, & Gynecological Cancer), End use (Hospital, Standalone Radiation Therapy Center)– Global Forecast, 2023-2032

Intensity Modulated Radiation Therapy Market Size

Intensity Modulated Radiation Therapy Market size was valued at USD 2.2 billion in 2022 and is estimated to register a CAGR of over 5.2% between 2023 and 2032. This therapy is an advanced technique in the field of radiation therapy designed to provide precise and targeted radiation doses to cancerous tumors while reducing the exposure to surrounding healthy tissues. Increasing prevalence of cancer is one of the prominent factors accelerating market growth.

According to the American Cancer Society, in 2022, an estimated 1.9 million new cases of cancer were diagnosed in the U.S. The commonly occurring cancers were breast cancer, prostate cancer, melanoma and others. Hence, surging cancer cases are expected to enhance the overall business progress.
 

Radiation therapy is an integrated part of modern comprehensive cancer management. Over the past decade, radiotherapy has come on leaps and bounds with several major technological breakthroughs that have increased precision and limited collateral damage. This means clinicians are able to boost doses, killing tumors more effectively, while further sparing surrounding healthy tissue. As technology continues to advance, the field of radiation therapy is likely to see further innovations which will enhance treatment outcomes and improve the quality of life for cancer patients.
 

COVID-19 Impact

Intensity modulated radiation therapy market witnessed moderately negative impact in early months of the pandemic. Several healthcare facilities experienced disruption in their regular operations due to the surge in COVID-19 cases. This led to the postponement or cancellation of elective procedures, including non-urgent IMRT treatments. Additionally, patients faced delay in receiving their scheduled radiation therapy sessions, potentially affecting the effectiveness of their treatment plans. Also, due to restrictions imposed by the government, slowed down the supply chain and distribution network of various radiotherapy companies. Hence, aforementioned factors impacted the market amid COVID-19.
 

Intensity Modulated Radiation Therapy Market Trends

The incidence of cancer is increasing rapidly globally; therefore, it is important to set up cancer awareness and knowledge amongst the population of every age. The awareness campaigns regarding cancer are designed to spread awareness among the large population throughout the globe. For instance, in India each year the National Cancer Awareness Day is observed on November 7. This campaign aims to raise awareness about cancer prevention and the need for its early detection. Such scenarios will fuel the overall industry progression.
 

• Additionally, the Breast Cancer Programme by the Union for International Cancer Control (UICC) addresses the immediate needs of individuals, contributing to the hastening of progress in the fight against breast cancer. This awareness programme strengthens and engages the global breast cancer community, with the overall goal of contributing to the reduction of premature deaths from breast cancer and improving the quality of life.
   

Intensity Modulated Radiation Therapy Market Analysis

The market by radiation type is categorized into proton, electron, photon, and carbon-ion radiation. The proton radiation therapy segment garnered USD 420 million revenue size in the year 2022.

• Proton therapy offers several advantages, its use is often considered in specific clinical scenarios, and the choice of treatment modality depends on factors such as the type and location of tumor, patient's overall health, and the treatment goal.
   
• Ongoing advancements in proton therapy including pencil beam scanning and intensity-modulated proton therapy (IMPT), contribute to improved treatment precision and the ability to deliver highly conformal doses of radiation.
   

Thus, increasing adoption of proton therapy, and rising healthcare expenditure contribute to market expansion.
 

Based on application, the intensity modulated radiation therapy market is segmented into cancer types including prostate, lung, breast, brain, gynecological coupled with other applications. The breast cancer segment dominated the market and accounted for over 26% business share in the year 2022.
 

• The growth can be attributed to the increasing prevalence of breast cancer. For instance, according to the American Cancer Society, in 2023, 297,790 new cases of breast cancer were estimated to be diagnosed, and around 43,700 related deaths are expected to occur in the U.S. alone.
   
• Moreover, as per the WHO, in 2021, breast cancer was the most common type of cancer at a global level, with new cases surpassing 2.3 million. Such high prevalence rate of the disease is expected to bolster segment development.
   

Based on end-use, the intensity modulated radiation therapy market is segmented into hospitals, and standalone radiation therapy centers. The hospitals segment dominated the by accounting for over 52% business share in the year 2022.
 

• The growth is attributable to the availability of emergency facilities, well established healthcare infrastructure and presence of skilled healthcare professionals. Increasing number of patient visits to hospitals for effective treatment and better facilities will result in higher segment progression.
   
• Hospitals are equipped with highly advanced technological products and serve as a base for most of the surgeries carried out worldwide, thus improving patient outcomes and favoring market expansion.
   

U.S. intensity modulated radiation therapy market accounted for over USD 766 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

• The rising incidence of cancer in the U.S. contributes to the increased demand for advanced and effective cancer treatment modalities.
   
• Additionally, the availability of advanced healthcare facilities, including those equipped with state-of-the-art radiation therapy equipment, influences the adoption of IMRT. Major medical centers and cancer treatment facilities in the U.S. are more likely to offer advanced treatment options such as intensity modulated radiation therapy.
   

Moreover, presence of several market participants focusing on developing innovative products for better patient management will prove advantageous for the market expansion.
 

Intensity Modulated Radiation Therapy Market Share

The intensity modulated radiation therapy industry is fragmented, with key players including Siemens Healthineers, IBA, Hitachi, Ltd., and others dominating the market space. These companies focus on product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in December 2022, IBA won a contract for the installation of ten proton therapy systems in Spain, which is being funded by the Amancio Ortega Foundation. The project valued over USD 229 million has been signed with the Spanish Ministry of Health under a public-private partnership agreement. Such contracts strengthen company’s position in the regional market.
 

Some of the eminent market participants operating in the intensity modulated radiation therapy industry include

• Siemens Healthineers
• ViewRay, Inc.
• IBA Dosimetry
• Mevion Medical Systems
• Hitachi, Ltd.
• RaySearch Laboratories AB
• Brainlab AG
• ProTom International
• Mitsubishi Electric Corporation
• Sumitomo Heavy Industries, Ltd.
• ProNova Solutions, LLC
• Varian Medical Systems, Inc.
• Elekta AB
• Accuray Incorporated
• Panacea Medical Technologies Pvt. Ltd.
   

Intensity Modulated Radiation Therapy Industry News

• In June 2022, Accuray unveiled a strategic collaboration with Limbus AI to bolster adaptive radiotherapy solutions. This partnership marked a significant milestone in expanding Accuray's product portfolio, showcasing the company's commitment to advancing cutting-edge technologies in the field of radiotherapy.
   
• In October 2021, Mevion Medical Systems has recently disclosed a strategic partnership with Hermes Advanced Therapy Systems, a move aimed at extending its presence in the Asian market. This collaboration is anticipated to facilitate Mevion Medical Systems in broadening its reach and reinforcing its position within the region.
   

Intensity modulated radiation therapy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Radiation Type, 2018 – 2032 (USD Million)

• Proton radiation
• Electron radiation
• Photon radiation
• Carbon ion radiation

By Application, 2018 – 2032 (USD Million)

• Prostate cancer
• Lung cancer
• Breast cancer
• Brain cancer
• Gynecological cancer
• Other applications

By End-use, 2018 – 2032 (USD Million)

• Hospitals
• Standalone radiation therapy centers

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa